Document is current
Any future updates will be listed below
-
Authors
Kruse, T. https://orcid.org/0000-0002-3431-7749
Shamai, S.
Leflerovà, D.
Wirth, B.
Heller, R.
Schloss, N.
Lehmann, H. C.
Brakemeier, S.
Hagenacker, T.
Braumann, B.
Wunderlich, G.
-
Clinical Trials BETA
Clinical trials referenced in this document:
drks00015842 at German Clinical Trials RegisterDocuments that mention this clinical trial
Oral functions in adult persons with spinal muscular atrophy compared to a healthy control group: a prospective cross-sectional study with a multimodal approach
https://doi.org/10.1186/s13023-024-03405-5
Objective measurement of oral function in adults with spinal muscular atrophy
https://doi.org/10.1186/s13023-023-02688-4
-
Funding
Funding for this research was provided by:
Biogen (ID 228101 / PO 254116)
Universitätsklinikum Köln
- License Information
-
More Information
Article History
Received: 28 November 2022
Accepted: 2 April 2023
First Online: 3 May 2023
Declarations
:
: The study was approved by the Ethics Committee of the Medical Faculty of the University of Cologne (Reference Number: 19–1137) and by the Ethics Committee of the Medical Faculty of the University of Essen (Reference Number: 21–9851-BO). Each subject provided informed consent.
: Not applicable.
: TK, and SS have received honoraria from Biogen for lectures. TK received financial research support from Biogen. TH received advisory and lecture honoraria and research support from Biogen, Roche and Novartis. DL, BB, SB, NS and GW have no conflicts of interests. BW received honoraria for lectures, workshops and interviews from Biogen and AveXis/Novartis. The funder had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.
